查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1507233

癌症疼痛管理市场、占有率、规模、趋势、行业分析报告：依疼痛类型、依药物类型、依癌症类型、依应用、依最终用途、依地区、依细分市场、预测，2024-2032年

Cancer Pain Management Market Share, Size, Trends, Industry Analysis Report, By Pain Type (Acute Pain, Chronic Pain); By Drug Type; By Cancer Type; By Application; By End-Use; By Region; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 117 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，到2032年，全球癌症疼痛治疗市场规模预计将达到 83.9 亿美元。本研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

癌症疼痛管理市场快速成长。癌症疼痛的范围可以从轻微到严重，并且以多种方式表现，包括尖锐的刺痛、疼痛、灼热感和持续性疼痛。癌症疼痛对生活品质有重大影响，并使癌症症状和治疗副作用恶化。此外，更有可能患上忧郁和焦虑。因此，适当的疼痛管理在癌症治疗中极为重要。

此外，癌症护理管理服务致力于在患者的整个癌症治疗过程中优化症状管理，包括疼痛管理。根据每位患者的独特需求和偏好提供全面、富有同情心的照护。有效的癌症疼痛管理需要肿瘤学家、疼痛专家、癌症护理团队、护士、社会工作者和其他医疗保健专业人员共同努力，以满足癌症患者复杂和个性化的需求。

近年来，针灸已成为缓解慢性疼痛的有效方法。这种传统中医治疗方法是将细针插入皮肤的特定区域并进行操作。儘管科学研究已经证明针灸对某些类型的疼痛有效，但其在治疗癌症相关疼痛方面的有效性证据有限。经皮神经电刺激（TENS）疗法使用透过放置在皮肤上的电极的低水平电流来引起身体反应并缓解疼痛。

癌症疼痛管理市场报告重点

具有缓解中度至重度疼痛特性的鸦片类药物在市场上占据主导地位。

非鸦片类药物领域预计在预测期内将以年复合成长率成长，因为它主要有效治疗轻度至中度疼痛。

由于肺癌盛行率不断上升以及与肺癌相关的疼痛频率较高，肺癌细分市场占据了最大的市场占有率。

由于病患对医院环境的偏好和信任不断提高，医院领域显着加速了市场的发展。

由于癌症盛行率上升和医疗服务需求不断成长，北美地区主导了市场。

目录

第1章 简介

第2章 执行摘要

第3章 研究方法

第4章 全球癌症疼痛管理市场洞察

  • 癌症疼痛管理 - 产业概况
  • 癌症疼痛管理市场动态
    • 推动因素和机会
      • 人口老化加剧
      • 癌症疼痛管理技术的进步
    • 抑制因素和挑战
      • 治疗费用高
  • PESTLE分析
  • 癌痛治疗产业的趋势
  • 新冠肺炎（COVID-19）影响分析

第5章 全球癌痛治疗市场：依疼痛类型

  • 主要发现
  • 简介
  • 剧烈疼痛
  • 慢性疼痛

第6章 全球癌痛治疗市场：依药物类型

  • 主要发现
  • 简介
  • 鸦片类药物
  • 非鸦片类药物
  • 皮质类固醇
  • 抗忧郁药
  • 抗焦虑药
  • 抗惊厥药
  • 抗精神病药物

第7章 全球癌症疼痛治疗市场：依癌症类型

  • 主要发现
  • 简介
  • 肺癌
  • 大肠癌
  • 乳癌
  • 摄护腺癌
  • 血癌
  • 其他

第8章 全球癌痛治疗市场：依应用分类

  • 主要发现
  • 简介
  • 免疫治疗
  • 化疗
  • 放射治疗
  • 家庭治疗
  • 其他

第9章 全球癌痛治疗市场：依最终用途分类

  • 主要发现
  • 简介
  • 医院
  • 癌症治疗诊所
  • 其他

第10章 全球癌痛治疗市场：依地区

  • 主要发现
  • 简介
    • 癌症疼痛管理市场评估：依地区，2019-2032年
  • 北美
    • 北美：依疼痛类型，2019-2032年
    • 北美：依应用，2019-2032年
    • 北美：依药物类型，2019-2032年
    • 北美：依癌症类型，2019-2032年
    • 北美：依最终用途，2019-2032年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲：依疼痛类型，2019-2032年
    • 欧洲：依应用，2019-2032年
    • 欧洲：依药物类型，2019-2032年
    • 欧洲：依癌症类型，2019-2032年
    • 欧洲：依最终用途，2019-2032年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
  • 亚太地区
    • 亚太地区：依疼痛类型，2019-2032年
    • 亚太地区：依应用，2019-2032年
    • 亚太地区：依药物类型，2019-2032年
    • 亚太地区：依癌症类型，2019-2032年
    • 亚太地区：依最终用途，2019-2032年
    • 中国
    • 印度
    • 日本
    • 马来西亚
    • 印尼
    • 韩国
  • 中东、非洲
    • 中东和非洲：依疼痛类型，2019-2032年
    • 中东与非洲：依应用，2019-2032年
    • 中东和非洲：依药物类型，2019-2032年
    • 中东和非洲：依癌症类型，2019-2032年
    • 中东和非洲：依最终用途，2019-2032年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
  • 拉丁美洲
    • 拉丁美洲：依疼痛类型，2019-2032年
    • 拉丁美洲：依应用，2019-2032年
    • 拉丁美洲：依药物类型，2019-2032年
    • 拉丁美洲：依癌症类型，2019-2032年
    • 拉丁美洲：依最终用途，2019-2032年
    • 墨西哥
    • 巴西
    • 阿根廷

第11章 竞争态势

  • 扩张与收购分析
    • 扩张
    • 收购
  • 伙伴关係/协作/协议/揭露

第12章 公司简介

  • BioDelivery Sciences
  • Daiichi Sankyo
  • Eli Lilly & Company
  • Endo Pharmaceuticals
  • Johnson & Johnson Inc
  • Mallinckrodt Pharmaceuticals
  • Pfizer Inc
  • Prostrakan Group
  • Sanofi S.A.
  • Teva Pharmaceuticals
Product Code: PM1320

The global cancer pain management market size is expected to reach USD 8.39 billion by 2032, according to a new study by Polaris Market Research. The report "Cancer Pain Management Market Share, Size, Trends, Industry Analysis Report, By Pain Type (Acute Pain, Chronic Pain); By Drug Type; By Cancer Type; By Application; By End-Use; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The cancer pain management market is witnessing rapid growth. Cancer pain can range from mild to severe and present in various forms, such as sharp stabbing pain, tingling, burning sensation, or a persistent ache. The impact of cancer pain on your quality of life is significant, worsening cancer symptoms and treatment side effects. Additionally, it can heighten the likelihood of developing depression and anxiety. Therefore, proper pain management is crucial in cancer treatment.

Additionally, cancer care management services focus on optimizing symptom management, including pain control, throughout the cancer journey of the patient. They provide holistic and compassionate care tailored to each patient's unique needs and preferences. Effective cancer pain management requires a collaborative effort from oncologists, pain specialists, cancer care teams, nurses, social workers, and other healthcare professionals to address the complex and individualized needs of cancer patients.

In recent years, additional methods that could be beneficial in alleviating chronic pain include acupuncture. This traditional Chinese medicine practice entails the insertion and manipulation of thin needles into specific areas of the skin. While scientific research has demonstrated the effectiveness of acupuncture in treating certain types of pain, there is limited evidence regarding its efficacy in managing cancer-related pain. Transcutaneous electrical nerve stimulation (TENS) therapy involves the application of a low-level electrical current through electrodes placed on the skin, eliciting a response from the body that helps alleviate pain.

Cancer Pain Management Market Report Highlights

The opioids segment dominated the market, largely attributable to their property to alleviate moderate to severe pain.

The non-opioids drug segment is projected to grow at a CAGR during the projected period, mainly driven by its effectiveness in managing mild to moderate pain.

The lung cancer segment accounted for the largest market share, attributed to the rising prevalence of lung cancer, a higher frequency of pain related to lung cancer.

The hospitals segment dominated the market highly accelerated due to the increasing preference and trust of patients towards hospital settings.

The North America region dominated the market attributed to the increasing prevalence of cancer has created a greater demand for healthcare services.

The global key market players include BioDelivery Sciences, Daiichi Sankyo, Eli Lilly & Company, Endo Pharmaceuticals, Johnson & Johnson Inc., etc.

Polaris Market Research has segmented the cancer pain management market report based on pain type, drug type, cancer type, application, end-use, and region:

Cancer Pain Management, Pain Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Acute Pain
  • Chronic Pain

Cancer Pain Management, Drug Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Opioid
  • Morphine
  • Fentanyl
  • Others
  • Non-opioids
  • Non-steroidal anti-inflammatory drug
  • Acetaminophen
  • Corticosteroids
  • Anti-depressants
  • Anti-anxiety drugs
  • Anti-convulsant drugs
  • Nerve Blockers

Cancer Pain Management, Cancer Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Lung Cancer
  • Colorectal cancer
  • Breast cancer
  • Prostate cancer
  • Blood cancer
  • Others

Cancer Pain Management, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Immunotherapy
  • Chemotherapy
  • Radiotherapy
  • Home Therapy
  • Others

Cancer Pain Management, End-Use Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospitals
  • Cancer Care Clinics
  • Others

Cancer Pain Management, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Australia
  • Malaysia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Cancer Pain Management Market Insights

  • 4.1. Cancer Pain Management - Industry Snapshot
  • 4.2. Cancer Pain Management Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Geriatric Population
      • 4.2.1.2. Rising Technology in Cancer Pain Management
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Treatment Costs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Cancer Pain Management Industry Trends
  • 4.6. COVID-19 Impact Analysis

5. Global Cancer Pain Management Market, by Pain Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • 5.3. Acute Pain
    • 5.3.1. Global Cancer Pain Management Market, by Acute Pain, by Region, 2019-2032 (USD Billion)
  • 5.4. Chronic Pain
    • 5.4.1. Global Cancer Pain Management Market, by Chronic Pain, by Region, 2019-2032 (USD Billion)

6. Global Cancer Pain Management Market, by Drug Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • 6.3. Opioid
    • 6.3.1. Global Cancer Pain Management Market, by Opioid, by Region, 2019-2032 (USD Billion)
    • 6.3.2. Morphine
      • 6.3.2.1. Global Cancer Pain Management Market, by Morphine, by Region, 2019-2032 (USD Billion)
    • 6.3.3. Fentanyl
      • 6.3.3.1. Global Cancer Pain Management Market, by Fentanyl, by Region, 2019-2032 (USD Billion)
    • 6.3.4. Others
      • 6.3.4.1. Global Cancer Pain Management Market, by Others, by Region, 2019-2032 (USD Billion)
  • 6.4. Non-opioids
    • 6.4.1. Global Cancer Pain Management Market, by Non-opioids, by Region, 2019-2032 (USD Billion)
    • 6.4.2. Non-steroidal anti-inflammatory drug
      • 6.4.2.1. Global Cancer Pain Management Market, by Non-steroidal anti-inflammatory drug, by Region, 2019-2032 (USD Billion)
    • 6.4.3. Acetaminophen
      • 6.4.3.1. Global Cancer Pain Management Market, by Acetaminophen, by Region, 2019-2032 (USD Billion)
  • 6.5. Corticosteroids
    • 6.5.1. Global Cancer Pain Management Market, by Corticosteroids, by Region, 2019-2032 (USD Billion)
  • 6.6. Anti-depressants
    • 6.6.1. Global Cancer Pain Management Market, by Anti-depressants, by Region, 2019-2032 (USD Billion)
  • 6.7. Anti-anxiety drugs
    • 6.7.1. Global Cancer Pain Management Market, by Anti-anxiety drugs, by Region, 2019-2032 (USD Billion)
  • 6.8. Anti-convulsant drugs
    • 6.8.1. Global Cancer Pain Management Market, by Anti-convulsant drugs, by Region, 2019-2032 (USD Billion)
  • 6.9. Nerve Blockers
    • 6.9.1. Global Cancer Pain Management Market, by Nerve Blockers, by Region, 2019-2032 (USD Billion)

7. Global Cancer Pain Management Market, by Cancer Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • 7.3. Lung Cancer
    • 7.3.1. Global Cancer Pain Management Market, by Lung Cancer, by Region, 2019-2032 (USD Billion)
  • 7.4. Colorectal cancer
    • 7.4.1. Global Cancer Pain Management Market, by Colorectal cancer, by Region, 2019-2032 (USD Billion)
  • 7.5. Breast cancer
    • 7.5.1. Global Cancer Pain Management Market, by Breast cancer, by Region, 2019-2032 (USD Billion)
  • 7.6. Prostate cancer
    • 7.6.1. Global Cancer Pain Management Market, by Prostate cancer, by Region, 2019-2032 (USD Billion)
  • 7.7. Blood cancer
    • 7.7.1. Global Cancer Pain Management Market, by Blood cancer, by Region, 2019-2032 (USD Billion)
  • 7.8. Others
    • 7.8.1. Global Cancer Pain Management Market, by Others, by Region, 2019-2032 (USD Billion)

8. Global Cancer Pain Management Market, by Application

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • 8.3. Immunotherapy
    • 8.3.1. Global Cancer Pain Management Market, by Immunotherapy, by Region, 2019-2032 (USD Billion)
  • 8.4. Chemotherapy
    • 8.4.1. Global Cancer Pain Management Market, by Chemotherapy, by Region, 2019-2032 (USD Billion)
  • 8.5. Radiotherapy
    • 8.5.1. Global Cancer Pain Management Market, by Radiotherapy, by Region, 2019-2032 (USD Billion)
  • 8.6. Home Therapy
    • 8.6.1. Global Cancer Pain Management Market, by Home Therapy, by Region, 2019-2032 (USD Billion)
  • 8.7. Others
    • 8.7.1. Global Cancer Pain Management Market, by Others, by Region, 2019-2032 (USD Billion)

9. Global Cancer Pain Management Market, by End-Use

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • 9.3. Hospitals
    • 9.3.1. Global Cancer Pain Management Market, by Hospitals, by Region, 2019-2032 (USD Billion)
  • 9.4. Cancer Care Clinics
    • 9.4.1. Global Cancer Pain Management Market, by Cancer Care Clinics, by Region, 2019-2032 (USD Billion)
  • 9.5. Others
    • 9.5.1. Global Cancer Pain Management Market, by Others, by Region, 2019-2032 (USD Billion)

10. Global Cancer Pain Management Market, by Geography

  • 10.1. Key findings
  • 10.2. Introduction
    • 10.2.1. Cancer Pain Management Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 10.3. Cancer Pain Management Market - North America
    • 10.3.1. North America: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
    • 10.3.2. North America: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
    • 10.3.3. North America: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
    • 10.3.4. North America: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
    • 10.3.5. North America: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.3.6. Cancer Pain Management Market - U.S.
      • 10.3.6.1. U.S.: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.3.6.2. U.S.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.3.6.3. U.S.: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.3.6.4. U.S.: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.3.6.5. U.S.: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.3.7. Cancer Pain Management Market - Canada
      • 10.3.7.1. Canada: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.3.7.2. Canada.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.3.7.3. Canada: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.3.7.4. Canada: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.3.7.5. Canada: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • 10.4. Cancer Pain Management Market - Europe
    • 10.4.1. Europe: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
    • 10.4.2. Europe.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
    • 10.4.3. Europe: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
    • 10.4.4. Europe: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
    • 10.4.5. Europe: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.4.6. Cancer Pain Management Market - UK
      • 10.4.6.1. UK: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.4.6.2. UK.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.4.6.3. UK: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.4.6.4. UK: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.4.6.5. UK: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.4.7. Cancer Pain Management Market - France
      • 10.4.7.1. France: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.4.7.2. France.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.4.7.3. France: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.4.7.4. France: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.4.7.5. France: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.4.8. Cancer Pain Management Market - Germany
      • 10.4.8.1. Germany: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.4.8.2. Germany.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.4.8.3. Germany: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.4.8.4. Germany: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.4.8.5. Germany: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.4.9. Cancer Pain Management Market - Italy
      • 10.4.9.1. Italy: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.4.9.2. Italy.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.4.9.3. Italy: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.4.9.4. Italy: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.4.9.5. Italy: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.4.10. Cancer Pain Management Market - Spain
      • 10.4.10.1. Spain: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.4.10.2. Spain.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.4.10.3. Spain: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.4.10.4. Spain: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.4.10.5. Spain: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.4.11. Cancer Pain Management Market - Netherlands
      • 10.4.11.1. Netherlands: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.4.11.2. Netherlands.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.4.11.3. Netherlands: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.4.11.4. Netherlands: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.4.11.5. Netherlands: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.4.12. Cancer Pain Management Market - Russia
      • 10.4.12.1. Russia: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.4.12.2. Russia.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.4.12.3. Russia: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.4.12.4. Russia: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.4.12.5. Russia: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • 10.5. Cancer Pain Management Market - Asia Pacific
    • 10.5.1. Asia Pacific: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
    • 10.5.2. Asia Pacific.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
    • 10.5.3. Asia Pacific: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
    • 10.5.4. Asia Pacific: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
    • 10.5.5. Asia Pacific: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.5.6. Cancer Pain Management Market - China
      • 10.5.6.1. China: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.5.6.2. China.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.5.6.3. China: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.5.6.4. China: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.5.6.5. China: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.5.7. Cancer Pain Management Market - India
      • 10.5.7.1. India: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.5.7.2. India.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.5.7.3. India: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.5.7.4. India: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.5.7.5. India: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.5.8. Cancer Pain Management Market - Japan
      • 10.5.8.1. Japan: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.5.8.2. Japan.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.5.8.3. Japan: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.5.8.4. Japan: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.5.8.5. Japan: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.5.9. Cancer Pain Management Market - Malaysia
      • 10.5.9.1. Malaysia: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.5.9.2. Malaysia.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.5.9.3. Malaysia: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.5.9.4. Malaysia: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.5.9.5. Malaysia: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.5.10. Cancer Pain Management Market - Indonesia
      • 10.5.10.1. Indonesia: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.5.10.2. Indonesia.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.5.10.3. Indonesia: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.5.10.4. Indonesia: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.5.10.5. Indonesia: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.5.11. Cancer Pain Management Market - South Korea
      • 10.5.11.1. South Korea: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.5.11.2. South Korea.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.5.11.3. South Korea: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.5.11.4. South Korea: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.5.11.5. South Korea: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • 10.6. Cancer Pain Management Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
    • 10.6.2. Middle East & Africa: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
    • 10.6.3. Middle East & Africa: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
    • 10.6.4. Middle East & Africa: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
    • 10.6.5. Middle East & Africa: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.6.6. Cancer Pain Management Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.6.6.2. Saudi Arabia.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.6.6.3. Saudi Arabia: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.6.6.4. Saudi Arabia: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.6.6.5. Saudi Arabia: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.6.7. Cancer Pain Management Market - UAE
      • 10.6.7.1. UAE: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.6.7.2. UAE.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.6.7.3. UAE: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.6.7.4. UAE: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.6.7.5. UAE: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.6.8. Cancer Pain Management Market - Israel
      • 10.6.8.1. Israel: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.6.8.2. Israel.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.6.8.3. Israel: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.6.8.4. Israel: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.6.8.5. Israel: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.6.9. Cancer Pain Management Market - South Africa
      • 10.6.9.1. South Africa: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.6.9.2. South Africa.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.6.9.3. South Africa: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.6.9.4. South Africa: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.6.9.5. South Africa: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • 10.7. Cancer Pain Management Market - Latin America
    • 10.7.1. Latin America: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
    • 10.7.2. Latin America.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
    • 10.7.3. Latin America: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
    • 10.7.4. Latin America: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
    • 10.7.5. Latin America: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.7.6. Cancer Pain Management Market - Mexico
      • 10.7.6.1. Mexico: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.7.6.2. Mexico.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.7.6.3. Mexico: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.7.6.4. Mexico: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.7.6.5. Mexico: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.7.7. Cancer Pain Management Market - Brazil
      • 10.7.7.1. Brazil: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.7.7.2. Brazil.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.7.7.3. Brazil: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.7.7.4. Brazil: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.7.7.5. Brazil: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.7.8. Cancer Pain Management Market - Argentina
      • 10.7.8.1. Argentina: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.7.8.2. Argentina.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.7.8.3. Argentina: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.7.8.4. Argentina: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.7.8.5. Argentina: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. BioDelivery Sciences
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. Daiichi Sankyo
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. Eli Lilly & Company
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. Endo Pharmaceuticals
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. Johnson & Johnson Inc
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Mallinckrodt Pharmaceuticals
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. Pfizer Inc
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. Prostrakan Group
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. Sanofi S.A.
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. Teva Pharmaceuticals
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development

List of Tables

  • Table 1 Global Cancer Pain Management Market, by Pain Type, by Region, 2019-2032 (USD Billion)
  • Table 2 Global Cancer Pain Management Market, by Drug Type, by Region, 2019-2032 (USD Billion)
  • Table 3 Global Cancer Pain Management Market, by Cancer Type, by Region, 2019-2032 (USD Billion)
  • Table 4 Global Cancer Pain Management Market, by End-Use, by Region, 2019-2032 (USD Billion)
  • Table 5 Global Cancer Pain Management Market, by Application, by Region, 2019-2032 (USD Billion)
  • Table 6 North America: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 7 North America: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 8 North America: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 9 North America: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 10 North America: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 11 U.S.: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 12 U.S.: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 13 U.S.: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 14 U.S.: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 15 U.S.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 16 Canada: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 17 Canada: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 18 Canada: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 19 Canada: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 20 Canada: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 21 Europe: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 22 Europe: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 23 Europe: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 24 Europe: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 25 Europe: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 26 Germany: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 27 Germany: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 28 Germany: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 29 Germany: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 30 Germany: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 31 France: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 32 France: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 33 France: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 34 France: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 35 France: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 36 UK: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 37 UK: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 38 UK: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 39 UK: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 40 UK: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 41 Italy: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 42 Italy: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 43 Italy: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 44 Italy: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 45 Italy: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 46 Netherlands: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 47 Netherlands: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 48 Netherlands: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 49 Netherlands: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 50 Netherlands: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 51 Spain: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 52 Spain: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 53 Spain: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 54 Spain: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 55 Spain: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 56 Russia: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 57 Russia: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 58 Russia: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 59 Russia: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 60 Russia: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 61 Asia Pacific: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 62 Asia Pacific: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 63 Asia Pacific: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 64 Asia Pacific: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 65 Asia Pacific: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 66 China: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 67 China: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 68 China: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 69 China: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 70 China: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 71 Japan: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 72 Japan: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 73 Japan: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 74 Japan: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 75 Japan: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 76 India: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 77 India: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 78 India: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 79 India: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 80 India: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 81 Indonesia: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 82 Indonesia: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 83 Indonesia: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 84 Indonesia: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 85 Indonesia: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 86 Malaysia: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 87 Malaysia: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 88 Malaysia: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 89 Malaysia: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 90 Malaysia: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 91 South Korea: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 92 South Korea: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 93 South Korea: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 94 South Korea: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 95 South Korea: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 96 Latin America: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 97 Latin America: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 98 Latin America: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 99 Latin America: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 100 Latin America: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 101 Brazil: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 102 Brazil: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 103 Brazil: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 104 Brazil: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 105 Brazil: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 106 Mexico: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 107 Mexico: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 108 Mexico: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 109 Mexico: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 110 Mexico: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 111 Argentina: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 112 Argentina: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 113 Argentina: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 114 Argentina: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 115 Argentina: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 116 Middle East & Africa: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 117 Middle East & Africa: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 118 Middle East & Africa: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 119 Middle East & Africa: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 120 Middle East & Africa: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 121 UAE: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 122 UAE: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 123 UAE: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 124 UAE: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 125 UAE: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 126 Saudi Arabia: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 127 Saudi Arabia: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 128 Saudi Arabia: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 129 Saudi Arabia: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 130 Saudi Arabia: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 131 South Africa: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 132 South Africa: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 133 South Africa: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 134 South Africa: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 135 South Africa: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 136 Israel: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 137 Israel: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 138 Israel: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 139 Israel: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 140 Israel: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Cancer Pain Management Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Pain Type
  • Figure 7. Global Cancer Pain Management Market, by Pain Type, 2021 & 2030 (USD Billion)
  • Figure 8. Market by Drug Type
  • Figure 9. Global Cancer Pain Management Market, by Drug Type, 2021 & 2030 (USD Billion)
  • Figure 10. Market by Cancer Type
  • Figure 11. Global Cancer Pain Management Market, by Cancer Type, 2021 & 2030 (USD Billion)
  • Figure 12. Market by End-Use
  • Figure 13. Global Cancer Pain Management Market, by End-Use, 2021 & 2030 (USD Billion)
  • Figure 14. Market by Application
  • Figure 15. Global Cancer Pain Management Market, by Application, 2021 & 2030 (USD Billion)